2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk

QR Code

2019 ESC/EAS Guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk

The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

Saved in:

Bibliographic Details
Main Authors:	Francois Mach, Colin Baigent, Alberico L. Catapano, Konstantinos C. Koskinas, Manuela Casula, Lina Badimon, M. John Chapman, Guy G. De Backer, Victoria Delgado, Brian A. Ference, Ian M. Graham, Alison Halliday, Ulf Landmesser, Borislava Mihaylova, Terje R. Pedersen, Gabriele Riccardi, Dimitrios J. Richter, Marc S. Sabatine, Marja-Riitta Taskinen, Lale Tokgozoglu, Olov Wiklund
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2020-06-01
Series:	Российский кардиологический журнал
Subjects:	guidelines dyslipidaemias cholesterol triglycerides low-density lipoproteins high-density lipoproteins apolipoprotein b lipoprotein(a) lipoprotein remnants total cardiovascular risk treatment (lifestyle) treatment (drugs)
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/3826
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

2016 ESC/EAS GUIDELINES FOR THE MANAGEMENT OF DYSLIPIDAEMIAS
by: Alberico L. Catapano, et al.
Published: (2017-06-01)

Serum Lipid Profile in Uterine Fibroids Patients Attending a Tertiary Healthcare: A Cross-sectional Study
by: Medowelie Matthew, et al.
Published: (2025-07-01)

Addressing Dyslipidaemia in Advanced CKD: Insights from a Secondary Care Cohort
by: Tom Siby, et al.
Published: (2025-05-01)

Features and quantitative characteristics of the interaction of benzo[a]pyrene with fractions of the human blood plasma lipoproteins
by: L. M. Polyakov, et al.
Published: (2021-04-01)

Uptake of cholesterol esters being a part of the different fractions of blood plasma lipoproteins by rats organs and tissues
by: L. M. Polyakov, et al.
Published: (2020-01-01)

Impact of COVID-19 on pro- and antiatherogenic lipoproteins (cross-sectional population study)
by: P. S. Sadovnikov, et al.
Published: (2024-10-01)

Effect of aqueous extract of olive (Olea europaea) fruit on lipid profile in female rabbits
by: Baghdad Science Journal
Published: (2010-12-01)

VARIABILITY IN LEVELS OF LOW-DENSITY LIPOPROTEINS CHOLESTEROL IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA DEPENDING ON AGE AND SEX AND ITS IMPORTANCE IN THE DIAGNOSIS OF THIS DISEASE
by: V. А. Korneva, et al.
Published: (2017-03-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

Serum albumin combined with high-density lipoprotein cholesterol as a novel marker to predict coronary heart disease: are their associations multiplicative or rateable?
by: Li He, et al.
Published: (2025-07-01)

BLOOD LIPOPROTEINS AS A PLATFORM FOR TRANSPORT OF HYDROPHILIC AND HYDROPHOBIC COMPOUNDS
by: L. M. Polyakov, et al.
Published: (2019-09-01)

Beyond LDL-C: discordant small dense LDL cholesterol stratifies hypertension risk in a Chinese longitudinal cohort
by: Xiaofei Wu, et al.
Published: (2025-06-01)

RUSSIAN GUIDELINES ON FAMILIAL HYPERCHOLESTEROLEMIA DIAGNOSIS AND TREATMENT
by: article Editorial
Published: (2017-06-01)

High density lipoproteins of blood plasma as a transport form of actinomycin D
by: L. M. Polyakov, et al.
Published: (2019-01-01)

Comparison of the effect of the alcoholic extract of leaves and fruits of hawthorn plant Crataegus azarolus with the drug simvastatin in its effect in reducing cardiovascular disease in male rabbits with experimental fat disorder
by: Muhanned H. Mukhlif Al-Obaidy, et al.
Published: (2018-08-01)

Analysis of risk factors for aortic stenosis in patients with familial hypercholesterolemia
by: V. A. Korneva, et al.
Published: (2025-02-01)

Elevated levels of lipoprotein(a) and low-density lipoprotein cholesterol in familial hypercholesterolemia patients: is dual primary prevention already in sight?
by: Alpo Vuorio, et al.
Published: (2025-07-01)

Lipid profile in hospitalized patients with COVID-19 depending on the outcome of its acute phase: data from the international registry "Dynamics analysis of comorbidities in SARS-CoV-2 infection survivors"
by: G. P. Arutyunov, et al.
Published: (2022-09-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease: From a Very Low-Density Lipoprotein Perspective
by: Yan Chen, et al.
Published: (2025-07-01)

Dyslipidemia in the Russian Federation: population data, associations with risk factors
by: O. M. Drapkina, et al.
Published: (2023-12-01)

Antibodies to low-density lipoproteins modified by malonic dialdehyde: contents in blood and role in atherogenesis
by: A. A. Ivanova, et al.
Published: (2025-01-01)

Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and Sarcopenic obesity in U.S. adults: a cross-sectional study
by: Jiao Liu, et al.
Published: (2025-08-01)

RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME
by: N. V. Perova, et al.
Published: (2015-09-01)

Linking Lipid Profile to Stress Urinary Incontinence in US Women: A National Cross-Sectional Study
by: Lu M, et al.
Published: (2025-06-01)

Review and analysis of 2023 Clinical Guidelines for Lipid Metabolism Disorders
by: I. V. Sergienko, et al.
Published: (2023-12-01)

High Density Lipoproteins: Metabolism, Biological Functions and Risk of cardiovascular pathology
by: N. N. Smirnova, et al.
Published: (2023-12-01)

PCSK9 Inhibitor Therapy as an Alternative for Statin Intolerance
by: K. O. Shnaider, et al.
Published: (2023-12-01)

INFLUENCE OF NICOTINIC ACID ON SUBFRACTIONAL SPECTRUM OF LOW, INTERMEDIATE AND HIGH DENSITY LIPOPROTEINS IN PATIENTS WITH HYPERLIPOPROTEINEMIA(а)
by: E. A. Utkina, et al.
Published: (2017-06-01)

LIPOPROTEIN APHERESIS: YESTERDAY, TODAY, TOMORROW. REVIEW
by: U. Julius, et al.
Published: (2018-09-01)

Lipoprotein (a) integrates monocyte-mediated thrombosis and inflammation in atherosclerotic cardiovascular disease
by: Robert S. Rosenson, et al.
Published: (2025-06-01)

Hypertriglyceridemia — current status of the problem. Part I: risks, physiology and pathophysiological aspects, classification and diagnostic problems
by: A. A. Semenkin, et al.
Published: (2025-02-01)

Correlation between psoriasis severity and dyslipidaemia in Iraqi patients
by: Jasim Samar Ahmed, et al.
Published: (2025-01-01)

Relationship of obesity, low-density lipoprotein cholesterol and myocardial perfusion in patients with risk factors and without atherosclerotic cardiovascular diseases
by: V. B. Sergienko, et al.
Published: (2021-03-01)

Diagnostic Characteristics of Familial Hypercholesterolemia in Children
by: Dinara I. Sadykova, et al.
Published: (2020-06-01)

Protective Effect of Thyme Extract on Albino Rats Exposed to Paraquat
by: Nazar M. Shareef Mahmood
Published: (2022-01-01)

Analysis of the low density lipoprotein receptor gene (<i>LDLR</i>) mutation spectrum in Russian familial hypercholesterolemia
by: V. B. Vasilyev, et al.
Published: (2022-06-01)

Diet Therapy in Children with Hypercholesteremia
by: Aelita A. Kamalova
Published: (2020-09-01)

Protective Effect of Thyme Extract on Albino Rats Exposed to Paraquat
by: Nazar M. Shareef Mahmood
Published: (2022-01-01)

Protective Effect of Thyme Extract on Albino Rats Exposed to Paraquat
by: Nazar M. Shareef Mahmood
Published: (2022-01-01)

Protective Effect of Thyme Extract on Albino Rats Exposed to Paraquat
by: Nazar M. Shareef Mahmood
Published: (2022-01-01)